Patents Assigned to Phytrix AG
  • Method for preparing seed extract
    Patent number: 7470441
    Abstract: The present invention provides pharmaceutical compositions comprising Mucuna pruriens seeds or one or more Mucuna pruriens seed components, substances, fractions or mixtures or substances obtained therefrom. Furthermore, the invention relates to the use of Mucuna pruriens seed powder or one or more Mucuna pruriens components, substances, fractions or mixtures or substances obtained therefrom for the preparation of a pharmaceutical composition for preventing, alleviating or treating neurological diseases. Additionally, the invention relates to the use of Mucuna pruriens seeds for the preparation of a pharmaceutical composition for neuroprotection or neurostimulation and to methods of preparing extracts of Mucuna pruriens which can be used for the preparation of a pharmaceutical composition for treating neurological diseases.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: December 30, 2008
    Assignee: Phytrix AG
    Inventors: Rob Van Der Giessen, C. Warren Olanow, Andrew Lees, Hildebert Wagner
  • Pharmaceutical compositions and uses comprising mucuna pruriens seed powder and extracts thereof in the treatment of neurological diseases
    Publication number: 20060165822
    Abstract: The present invention provides pharmaceutical compositions comprising Mucuna pruriens seeds or one or more Mucuna pruriens seed components, substances, fractions or mixtures or substances obtained therefrom. Furthermore, the invention relates to the use of Mucuna pruriens seed powder or one or more Mucuna pruriens components, substances, fractions or mixtures or substances obtained therefrom for the preparation of a pharmaceutical composition for preventing, alleviating or treating neurological diseases. Additionally, the invention relates to the use of Mucuna pruriens seeds for the preparation of a pharmaceutical composition for neuroprotection or neurostimulation and to methods of preparing extracts of Mucuna pruriens which can be used for the preparation of a pharmaceutical composition for treating neurological diseases.
    Type: Application
    Filed: October 2, 2003
    Publication date: July 27, 2006
    Applicant: Phytrix AG
    Inventors: Rob Van Der Giessen, C Olanow, Andrew Lees, Hildebert Wagner
  • Use of Phyllanthus for treating chronic inflammatory and fibrotic processes
    Patent number: 6586015
    Abstract: The present invention relates to the use of Phyllanthus for preventing or treating connective tissue proliferations, for maintaining the level of reduced glutathione, for inhibiting lipopolysaccharide (LPS)-induced nitric oxide synthase (NOS) and for inhibiting expression of the cyclooxygenase (COX-2) protein.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: July 1, 2003
    Assignee: Phytrix AG
    Inventors: Rolf Gebhardt, Angelika M. Vollmar, Michael P. Manns, Matthias Bahr, Hildebert Wagner, Gayane Hrachia Buniatian